One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their ...
FDA expands Casgevy CRISPR gene therapy to children aged 2+ with sickle cell disease and beta thalassemia, enabling earlier ...
Leishmaniasis cases are doubling at Ohio State's hospital as sand flies expand their range, while Dr. Satoskar prepares to ...
Vertex has secured a label expansion through the FDA's Commis | Vertex Pharmaceuticals has gained a label expansion from the ...
Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to ...
New World screwworm cases continue to mount as researchers test a new sterile fly technology to improve future eradication ...
The strongest political angle is that ordinary people are being asked to absorb the cost and risk of systems they did not ...
Some sci-fi movies get better as time go by, developing cult followings that recognize how relevant they remain decades later ...
Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...
Developing novel ways to refine, reduce and replace the use of animals in research and enhance animal and human health.
Hearing aids improve hearing by amplifying sounds. Researchers are exploring whether they may also support brain health in ...